Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid analgesics

A R Rushton1, J R Sneyd

  • 1Department of Anaesthesia, Derriford Hospital, Plymouth.

British Journal of Hospital Medicine
|February 5, 1997
PubMed
Summary
This summary is machine-generated.

New opioid drugs show promise for pain relief but still cause side effects. Remifentanil, an intravenous opioid, offers rapid effects and quick recovery due to its unique metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developments in procedural sedation for adults.

BJA education·2022
Same author

Patient-centred measurement of recovery from day-case surgery using wrist worn accelerometers: a pilot and feasibility study.

Anaesthesia·2020
Same author

Who watches the watchmen and the problem of recursive flea bites.

British journal of anaesthesia·2019
Same author

Attempting tracheal intubation without paralysis.

British journal of anaesthesia·2018
Same author

Quest for new drugs: a way to solve anaesthesia neurotoxicity?

British journal of anaesthesia·2018
Same author

Response to Serrao and Goodchild.

British journal of anaesthesia·2018

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Pain Management

Background:

  • Opioid analgesics are crucial for pain management but are limited by side effects.
  • Development of selective opioid receptor agonists aims to improve efficacy and safety.
  • Understanding opioid pharmacokinetics is essential for optimizing clinical use.

Purpose of the Study:

  • To review recent advancements in opioid pharmacology.
  • To highlight the potential and limitations of selective opioid receptor agents.
  • To discuss the pharmacokinetic properties of remifentanil.

Main Methods:

  • Literature review of recent developments in opioid pharmacology.
  • Analysis of studies on selective opioid receptor activity.
  • Examination of pharmacokinetic data for remifentanil.

Related Experiment Videos

Main Results:

  • Selective opioid receptor activity has not yet yielded analgesics without side effects.
  • Remifentanil exhibits rapid onset and short, predictable recovery.
  • Recovery from remifentanil is independent of infusion duration due to esterase metabolism.

Conclusions:

  • Despite progress, achieving potent analgesia without side effects remains a challenge.
  • Remifentanil's unique pharmacokinetic profile offers advantages in clinical settings requiring rapid control and recovery.
  • Further research into selective opioid receptor modulation is warranted.